Question Bank › Working for customers it could not have served a

Working for customers it could not have served a year ago

Working for customers it could not have served a year ago: the company's deliverable capability just stepped up a class

Calls Tested
498
Answered YES
35
Hit Rate
7%
rare by design

Regeneron Pharmaceuticals, Inc. (REGN) — this company's answers

NO on the Q4 2022 call 2023-02-03 C
The model's full reasoning — Q4 2022 call → NOWe need to determine if management conveys a capability step-change with all three elements: before/after, paying work, and early stage. Let's analyze the transcript. Key points: The company discusses various pipeline developments, commercial launches, and financials. The question asks about a capability that the company can now do that it couldn't a year ago, with real customers paying for it, and the business is still early. Look for specific statements about new capabilities. For example, the launch of aflibercept 8 mg is pending approval, not yet launched. Dupixent approvals in new indications? But that's more about expanding indications, not a capability step-change in production or delivery. The Libtayo transaction gave them full rights, but that's a business deal, not a capability. The most promising is the costimulatory bispecifics and the PSMAxCD28 data. But that's still in clinical trials, not paying customers. The question specifically says "REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW" - that implies commercial products. Consider the EYLEA franchise: they have EYLEA and are launching aflibercept 8 mg later. But that's not yet. Maybe the company's ability to manufacture? They mention a new manufacturing process for DUPIXENT that improves yields, but that's not a capability step-change in terms of what they can do for customers. The transcript mentions "we have initiated clinical studies for two new drug candidates" and "anticipate clinical trials starting or IND submission for up to 10 new therapeutic candidates this year" - that's R&D, not paying customers. The question is about a capability that the company can now do that it couldn't a year ago, and real customers are paying for it. That suggests a commercial product or service that is new and generating revenue. For example, the approval of Libtayo in combination with chemotherapy for NSCLC - that is a new indication, but the drug was already on the market for other indications. So it's not a new capability, just an expanded use. What about the international expansion? They mention building out international commercial infrastructure. But that's not a specific capability step-change. Perhaps the answer is NO because there is no clear statement of a before/after capability with paying customers. The company is still in clinical development for many things.

← Back to the full REGN analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company CAN NOW ACTUALLY DO SOMETHING — produce, deliver, serve, handle, or perform at a scale, specification, quality, or complexity — that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, with the business it enables still early? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent capability step-change with all three present: (1) A BEFORE/AFTER IN WHAT THE COMPANY CAN DO: management contrasts — directly or plainly in substance — what the company can now execute against what it could not previously execute: bigger orders or projects than it could formerly take, specifications or performance levels it could not formerly meet, volumes it could not formerly produce, customer classes it could not formerly support, or work it formerly had to decline or subcontract that it now performs itself; (2) THE CAPABILITY IS PROVEN BY PAYING WORK, NOT ASSERTED: real customers are currently paying for output that exercises the new capability — actual orders delivered, projects performed, volumes shipped, or engagements running now that would have been impossible for the company a year ago, described with operating substance; and (3) EARLY RELATIVE TO WHAT IT OPENS: management conveys that the class of business this capability admits the company to is mostly still ahead — the first such engagements are done or underway, more are forming, and the reported results reflect only the beginning of operating at the new level. Answer NO if the new capability is still being built, tested, or awaiting qualification with no paying work exercising it. NO if the step-up is routine incremental improvement rather than a change in what class of work the company can take. NO if the claim is generic ('expanded capabilities,' 'enhanced platform') without concrete before/after substance and paying proof. NO if the newly enabled business is already mature and fully in the numbers. NO if the capability story appears only in an analyst's question management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
HCKT The Hackett Group, Inc. Q1 2024 2024-05-08 C
LINC Lincoln Educational Services Corporation Q1 2024 2024-05-06 B+
HUYA HUYA Inc. Q4 2023 2024-03-19 C
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
SANG Sangoma Technologies Corporation Q2 2024 2024-02-08 D
OPAD Offerpad Solutions Inc. Q3 2023 2023-11-01 C
TGLS Tecnoglass Inc. Q2 2023 2023-08-08 A
CARS Cars.com Inc. Q1 2023 2023-05-06 B
TSSI TSS, Inc. Q4 2022 2023-04-03 D
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
M Macy's, Inc. Q4 2022 2023-03-02 D
CEIX CONSOL Energy Inc. Q4 2022 2023-02-07 B
KFY Korn Ferry Q4 2022 2022-06-22 B
ZVIA Zevia PBC Q1 2022 2022-05-12 B
CNXC Concentrix Corporation Q1 2022 2022-03-30 B
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
NGVT Ingevity Corporation Q4 2021 2022-02-25 B
VNDA Vanda Pharmaceuticals Inc. Q4 2021 2022-02-23 F
SLQT SelectQuote, Inc. Q2 2022 2022-02-07 F
EXP Eagle Materials Inc. Q3 2022 2022-01-27 B
LC LendingClub Corporation Q4 2021 2022-01-26 A
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
CRS Carpenter Technology Corporation Q4 2021 2021-08-01 A
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
LRN Stride, Inc. Q1 2019 2018-10-23 B
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
TOUR Tuniu Corporation Q4 2017 2018-03-14 D
HSTM HealthStream, Inc. Q3 2017 2017-10-24 C
PSX Phillips 66 Q4 2016 2017-02-03 C+
AEHR Aehr Test Systems Q2 2017 2017-01-05 F
NTCT NetScout Systems, Inc. Q2 2017 2016-10-27 D
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

TGLS · Q2 2023 → YESThe question is about whether management conveys a new capability that they can now do something they couldn't do a year ago, that customers are paying for now, and it's still early. YES Management explicitly contrasts the new capability against the prior limitation: extra capacity now enables them to sell stand-alone architectural glass and aluminum framing products that were previously allocated to window production due to capacity constraints. This is a clear before/after step-change in the class of work they can accept and perform. Real customers are already paying for this new output: the transcript states they have a little bit more installation in stand-alone product sales the rest of the year, and they are now very well positioned to increasingly service large homebuilders’ customers as well as demand for the stand-alone aluminum and glass products, with the absorption of new capacity and ability to offer a wider range of solutions to customers described as positive overall.
TACT · Q4 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES The transcript shows management describing a clear before/after step-change in casino and gaming printers: they could produce printers before, but now they have added a third line in Q3 and begun manufacturing on a fourth line in Q4, enabling them to meet demand and take market share that the prior competitor could not supply 12 months ago.
ZVIA · Q1 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES Management describes the launch of single-serve 12-ounce cans as a first-time capability: “we began selling Zevia’s soda in single cans for the first time in a 12-ounce sleek format,” now “available cold in several grocery retailers” with “some of which is shipping now.

More from the question bank

The product is disappearing into reorder rhyVolume records through a still-fixed gateNamed catch-up gapSelling something whose payoff to the buyer Paid to expand: the company's growth spendinTone of discovery: management sounds newly sAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.